Managed care
Southern California Permanente Medical Group
Southern California Permanente Medical Group was paid $25.36M by Medicaid between Oct 2018 and Dec 2024, across 309 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 27% of everything it billed.
33Billing provider infoSOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP
LANCASTER, CA 93534
LANCASTER, CA 93534
33aNPI1982863783assigned 06/06/2008
33bProvider typeHealth Maintenance Organization
28Total paid$25.36M
24GClaims1,163,882
24DCodes billed309
24AFirst – last monthOct 2018 – Dec 2024
Compared with peers
Next to other Health Maintenance Organization providers in California
Rank by total paid#10 of 151
Median peer was paid$59K
This provider vs. median429×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAVIDOFF, RAMIN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 38 | $0.00 | |
| 2019 | 140,527 | $220K | |
| 2020 | 129,419 | $1.67M | |
| 2021 | 176,110 | $3.55M | |
| 2022 | 199,480 | $4.45M | |
| 2023 | 243,770 | $6.36M | |
| 2024incomplete | 274,538 | $9.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 99,682 | 98,328 | $6.95M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.2% | 98,971 | 97,244 | $2.34M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2.8% | 10,494 | 10,482 | $721K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.2% | 31,840 | 31,306 | $558K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.2% | 5,638 | 5,637 | $555K |
| 91320 | 2.1% | 3,248 | 3,246 | $532K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.9% | 9,300 | 9,133 | $486K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.8% | 1,202 | 1,196 | $447K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.7% | 71,052 | 70,833 | $439K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.4% | 1,645 | 1,057 | $349K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.3% | 6,458 | 6,454 | $340K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 41,478 | 35,545 | $295K |
297 more codes
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.1% | 6,503 | $291K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.1% | 1,663 | $285K |
| 67028 | Intravitreal injection of a pharmacologic agent | 1.1% | 1,591 | $281K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 3,515 | $280K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 9,326 | $269K |
| 92015 | Determination of refractive state | 1.0% | 30,486 | $265K |
| 99441 | 1.0% | 8,271 | $262K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,126 | $244K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 2,683 | $240K |
| 90662 | <1% | 2,093 | $233K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 11,901 | $224K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,959 | $212K |
| 20610 | <1% | 2,154 | $210K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 8,775 | $210K |
| 90480 | <1% | 4,038 | $207K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 4,747 | $195K |
| 97161 | <1% | 2,353 | $191K | |
| 99443 | <1% | 1,717 | $172K | |
| 83880 | <1% | 2,754 | $161K | |
| 82565 | <1% | 25,087 | $152K | |
| 90837 | Psychotherapy session, about an hour | <1% | 2,668 | $151K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 9,607 | $137K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 898 | $137K |
| 80051 | <1% | 19,809 | $128K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 14,222 | $128K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 345 | $126K |
| 90686 | <1% | 24,509 | $122K | |
| 85027 | <1% | 39,019 | $120K | |
| 73562 | <1% | 4,296 | $118K | |
| 99442 | <1% | 2,092 | $112K | |
| 76830 | Ultrasound, transvaginal | <1% | 2,861 | $112K |
| 84460 | <1% | 18,942 | $110K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,042 | $108K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,982 | $107K |
| 73630 | <1% | 5,722 | $104K | |
| 0012A | <1% | 2,805 | $104K | |
| 0001A | <1% | 2,579 | $102K | |
| 77080 | <1% | 1,911 | $102K | |
| 92134 | <1% | 3,613 | $100K | |
| 0002A | <1% | 2,500 | $100K | |
| 76770 | <1% | 1,369 | $100K | |
| 0064A | <1% | 2,397 | $98K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,914 | $97K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 4,478 | $97K |
| 0011A | <1% | 2,604 | $96K | |
| 86141 | <1% | 7,846 | $95K | |
| 92551 | <1% | 24,636 | $90K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 5,131 | $86K |
| 84075 | <1% | 14,224 | $80K | |
| 82247 | <1% | 15,819 | $80K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 1,778 | $80K |
| 73030 | <1% | 3,476 | $78K | |
| 92133 | <1% | 3,095 | $77K | |
| 85610 | <1% | 15,507 | $75K | |
| 94060 | <1% | 1,021 | $72K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,024 | $72K |
| 76536 | <1% | 1,066 | $70K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 3,325 | $70K |
| 92002 | <1% | 2,605 | $63K | |
| 73610 | <1% | 3,781 | $63K | |
| 95800 | <1% | 358 | $62K | |
| 90674 | <1% | 5,342 | $60K | |
| 71250 | <1% | 278 | $58K | |
| 81003 | <1% | 30,561 | $57K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 3,421 | $56K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,415 | $56K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 178 | $54K |
| 84520 | <1% | 14,843 | $53K | |
| 72100 | <1% | 2,142 | $52K | |
| 84484 | <1% | 4,153 | $52K | |
| 73130 | <1% | 2,786 | $51K | |
| 94726 | <1% | 561 | $51K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 17,244 | $50K |
| 73564 | <1% | 1,541 | $48K | |
| 90651 | <1% | 1,936 | $48K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 452 | $47K |
| 84702 | <1% | 8,967 | $46K | |
| 82947 | <1% | 14,330 | $45K | |
| 94729 | <1% | 431 | $45K | |
| 84450 | <1% | 7,602 | $43K | |
| 0134A | <1% | 1,135 | $42K | |
| 92523 | <1% | 608 | $40K | |
| 73110 | <1% | 2,545 | $40K | |
| 62322 | <1% | 202 | $40K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,055 | $40K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 751 | $38K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,392 | $38K |
| 83690 | <1% | 7,562 | $36K | |
| 82570 | <1% | 5,351 | $35K | |
| 73502 | <1% | 729 | $34K | |
| 90750 | <1% | 434 | $34K | |
| 0004A | <1% | 847 | $34K | |
| 93971 | <1% | 186 | $34K | |
| 0124A | <1% | 1,062 | $32K | |
| 76642 | <1% | 694 | $31K | |
| 70486 | <1% | 278 | $31K | |
| 82310 | <1% | 3,998 | $30K | |
| 97165 | <1% | 586 | $29K | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 532 | $28K |
| 0071A | <1% | 687 | $28K | |
| 90677 | <1% | 730 | $28K | |
| 85730 | <1% | 5,100 | $27K | |
| 73140 | <1% | 1,773 | $25K | |
| 90670 | <1% | 2,097 | $25K | |
| 77065 | Tomosynthesis, mammo | <1% | 240 | $24K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,064 | $23K |
| 11102 | <1% | 156 | $23K | |
| 90734 | <1% | 569 | $23K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 39 | $23K |
| 92083 | <1% | 565 | $22K | |
| 85652 | <1% | 8,646 | $22K | |
| 0072A | <1% | 532 | $21K | |
| 84156 | <1% | 5,134 | $21K | |
| 0054A | <1% | 512 | $21K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,400 | $21K |
| 77066 | Tomosynthesis, mammo | <1% | 201 | $20K |
| 90656 | <1% | 3,521 | $20K | |
| 83735 | <1% | 3,120 | $20K | |
| 72040 | <1% | 818 | $19K | |
| 90679 | <1% | 107 | $18K | |
| 0031A | <1% | 442 | $17K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 483 | $16K |
| 85379 | <1% | 1,692 | $15K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 12,748 | $15K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,468 | $15K |
| 72050 | <1% | 376 | $14K | |
| 74018 | <1% | 1,261 | $14K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,266 | $14K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 24,948 | $13K |
| 20553 | <1% | 143 | $13K | |
| 95117 | <1% | 1,363 | $13K | |
| 73590 | <1% | 901 | $13K | |
| 73560 | <1% | 662 | $13K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,920 | $12K |
| 76813 | <1% | 293 | $12K | |
| 81329 | <1% | 491 | $12K | |
| 83921 | <1% | 450 | $12K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 287 | $11K |
| 73080 | <1% | 957 | $11K | |
| 95910 | <1% | 41 | $11K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 516 | $11K |
| 99173 | <1% | 13,311 | $11K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 13 | $10K |
| 76641 | <1% | 222 | $10K | |
| 92250 | <1% | 572 | $10K | |
| 72170 | <1% | 357 | $9K | |
| 92557 | <1% | 131 | $8K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 871 | $8K |
| 84100 | <1% | 1,613 | $8K | |
| 73660 | <1% | 538 | $8K | |
| 99177 | <1% | 5,399 | $8K | |
| 82550 | <1% | 1,363 | $8K | |
| 93308 | <1% | 91 | $8K | |
| 81002 | <1% | 5,896 | $7K | |
| 90715 | <1% | 467 | $7K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 308 | $7K |
| 87210 | <1% | 5,044 | $7K | |
| 98968 | <1% | 631 | $7K | |
| 71101 | <1% | 192 | $7K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 402 | $7K |
| 87449 | <1% | 441 | $6K | |
| 87324 | <1% | 427 | $6K | |
| 90648 | <1% | 2,909 | $6K | |
| 76706 | <1% | 28 | $6K | |
| 97597 | <1% | 38 | $6K | |
| 96415 | <1% | 62 | $5K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 198 | $5K |
| 98967 | <1% | 405 | $5K | |
| 90723 | <1% | 991 | $5K | |
| 85014 | <1% | 2,338 | $5K | |
| 73100 | <1% | 268 | $4K | |
| 92567 | <1% | 145 | $4K | |
| 85018 | <1% | 1,558 | $4K | |
| 82950 | <1% | 2,730 | $4K | |
| 82248 | <1% | 1,098 | $4K | |
| 96900 | <1% | 419 | $4K | |
| 81015 | <1% | 1,400 | $4K | |
| 11721 | <1% | 34 | $4K | |
| 0052A | <1% | 85 | $3K | |
| 84132 | <1% | 630 | $3K | |
| 85046 | <1% | 745 | $3K | |
| 90672 | <1% | 817 | $3K | |
| 74022 | <1% | 125 | $3K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 209 | $3K |
| 93296 | <1% | 40 | $3K | |
| 97162 | <1% | 52 | $3K | |
| 81025 | <1% | 1,190 | $3K | |
| 81206 | <1% | 24 | $3K | |
| 73090 | <1% | 347 | $3K | |
| 82105 | <1% | 507 | $3K | |
| 99201 | <1% | 358 | $3K | |
| 73552 | <1% | 65 | $3K | |
| 0051A | <1% | 60 | $2K | |
| 0074A | <1% | 69 | $2K | |
| 0154A | <1% | 65 | $2K | |
| 73522 | <1% | 52 | $2K | |
| 72070 | <1% | 120 | $2K | |
| 99219 | <1% | 12 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 13 | $2K |
| 90633 | <1% | 847 | $2K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 53 | $2K |
| 84550 | <1% | 359 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 590 | $2K |
| 93015 | <1% | 26 | $2K | |
| 74019 | <1% | 75 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 93 | $2K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,054 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,716 | $2K |
| 93271 | <1% | 12 | $2K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,465 | $1K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 95 | $1K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 62 | $1K |
| 73501 | <1% | 39 | $1K | |
| 0003A | <1% | 33 | $1K | |
| 17110 | <1% | 26 | $1K | |
| 82951 | <1% | 293 | $1K | |
| J1750 | Injection, iron dextran, 50 mg | <1% | 18 | $1K |
| 11900 | <1% | 24 | $1K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 40 | $1K |
| 93294 | <1% | 12 | $1K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 70 | $1K |
| 90660 | <1% | 181 | $1K | |
| 73060 | <1% | 47 | $1K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 12 | $987.20 |
| 87205 | <1% | 331 | $978.06 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 680 | $967.07 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 15 | $890.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 429 | $801.95 |
| 0034A | <1% | 19 | $743.92 | |
| 86580 | <1% | 132 | $660.00 | |
| 51798 | <1% | 40 | $650.90 | |
| 73565 | <1% | 26 | $645.00 | |
| 90655 | <1% | 164 | $644.00 | |
| 76881 | <1% | 43 | $630.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,380 | $600.40 |
| 91319 | <1% | 40 | $594.00 | |
| 90839 | <1% | 13 | $582.00 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 51 | $580.00 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 331 | $575.24 |
| 83605 | <1% | 32 | $570.00 | |
| 98966 | <1% | 107 | $525.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 12 | $500.00 |
| 72220 | <1% | 14 | $490.00 | |
| 0111A | <1% | 12 | $480.00 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 12 | $450.00 |
| 84295 | <1% | 114 | $430.00 | |
| 82962 | <1% | 139 | $429.84 | |
| 92511 | <1% | 12 | $420.00 | |
| 36000 | <1% | 24 | $420.00 | |
| 73650 | <1% | 14 | $400.00 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 86 | $389.50 |
| 82952 | <1% | 282 | $385.64 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 100 | $382.76 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 27 | $360.00 |
| 87631 | <1% | 15 | $320.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,395 | $311.19 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 47 | $283.50 |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 42 | $238.00 |
| 93272 | <1% | 12 | $237.00 | |
| 72081 | <1% | 27 | $206.06 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 13 | $180.00 |
| 99188 | <1% | 69 | $176.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12 | $150.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 252 | $145.00 |
| 90716 | <1% | 25 | $139.00 | |
| 59025 | Fetal non-stress test | <1% | 30 | $133.00 |
| 85049 | <1% | 16 | $120.00 | |
| 95012 | <1% | 38 | $112.00 | |
| 85045 | <1% | 24 | $110.00 | |
| 90707 | <1% | 13 | $95.00 | |
| 90700 | <1% | 38 | $74.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 155 | $71.95 |
| 99417 | Prolong home eval add 15m | <1% | 12 | $70.00 |
| 73000 | <1% | 14 | $69.60 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 12 | $67.70 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,074 | $65.24 |
| 90681 | <1% | 54 | $63.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 349 | $55.52 |
| 90661 | <1% | 987 | $49.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 22 | $47.52 |
| 87807 | <1% | 26 | $43.48 | |
| 82374 | <1% | 15 | $40.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 13 | $7.77 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 27 | $1.52 |
| G9920 | Screening performed and negative | <1% | 9,094 | $0.22 |
| 99051 | 0% | 2,765 | $0.00 | |
| 90756 | 0% | 12 | $0.00 | |
| 99221 | 0% | 12 | $0.00 | |
| 99024 | 0% | 711 | $0.00 | |
| 1036F | 0% | 23,404 | $0.00 | |
| 94010 | 0% | 13 | $0.00 | |
| 64566 | 0% | 15 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 0% | 18 | $0.00 |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 0% | 14 | $0.00 |
| 97010 | 0% | 24 | $0.00 | |
| 90688 | 0% | 17 | $0.00 | |
| 86140 | 0% | 62 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIDOFF, RAMIN (EXECUTIVE MEDICAL DIRECTOR)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.